Avantor Inc (AVTR)

$25.15

-0.31

(-1.22%)▲

Market is closed - opens 7 PM, 26 Apr 2024

Insights on Avantor Inc

  • Increasing Revenue

    Revenue is up for the last 2 quarters, 1.72B → 1.72B (in $), with an average increase of 0.2% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 108.4M → 98.5M (in $), with an average decrease of 9.1% per quarter

  • Vs ECL

    In the last 1 year, Ecolab Inc. has given 35.2% return, outperforming this stock by 0.9%

  • Vs LIN

    In the last 3 years, Avantor Inc has experienced a drawdown of -24.7%, however Linde Plc resisted the overall trend and outperformed by 21.6%

Performance

  • $24.98
    $25.39
    $25.15
    downward going graph

    0.68%

    Downside

    Day's Volatility :1.6%

    Upside

    0.93%

    downward going graph
  • $16.63
    $26.11
    $25.15
    downward going graph

    33.88%

    Downside

    52 Weeks Volatility :36.31%

    Upside

    3.68%

    downward going graph

Returns

PeriodAvantor IncSector (Health Care)Index (Russel 2000)
3 Months
10.99%
0.5%
0.0%
6 Months
28.84%
11.7%
0.0%
1 Year
34.35%
6.2%
2.2%
3 Years
-24.68%
13.5%
-23.0%

Highlights

Market Capitalization
17.3B
Book Value
$7.76
Earnings Per Share (EPS)
0.47
PE Ratio
54.17
Wall Street Target Price
27.09
Profit Margin
4.61%
Operating Margin TTM
12.94%
Return On Assets TTM
4.25%
Return On Equity TTM
6.35%
Revenue TTM
7.0B
Revenue Per Share TTM
10.31
Quarterly Revenue Growth YOY
-4.0%
Gross Profit TTM
2.6B
EBITDA
1.3B
Diluted Eps TTM
0.47
Quarterly Earnings Growth YOY
-0.33
EPS Estimate Current Year
1.01
EPS Estimate Next Year
1.24
EPS Estimate Current Quarter
0.22
EPS Estimate Next Quarter
0.23

Analyst Recommendation

Buy
    67%Buy
    32%Hold
    0
    0%Sell
Based on 28 Wall street analysts offering stock ratings for Avantor Inc(by analysts ranked 0 to 5 stars)
Based on 28 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
19
19
19
Hold
9
9
9
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 7.71%

Current $25.15
Target $27.09

Company Financials

FY18Y/Y Change
Revenue
5.9B
↑ 370.12%
Net Income
-86.9M
↓ 22.89%
Net Profit Margin
-1.48%
↑ 7.55%
FY19Y/Y Change
Revenue
6.0B
↑ 3.0%
Net Income
37.8M
↓ 143.5%
Net Profit Margin
0.63%
↑ 2.11%
FY20Y/Y Change
Revenue
6.4B
↑ 5.85%
Net Income
116.6M
↑ 208.47%
Net Profit Margin
1.82%
↑ 1.19%
FY21Y/Y Change
Revenue
7.4B
↑ 15.52%
Net Income
572.6M
↑ 391.08%
Net Profit Margin
7.75%
↑ 5.93%
FY22Y/Y Change
Revenue
4.9B
↓ 33.53%
Net Income
686.5M
↑ 19.89%
Net Profit Margin
13.98%
↑ 6.23%
FY23Y/Y Change
Revenue
7.0B
↑ 41.91%
Net Income
321.1M
↓ 53.23%
Net Profit Margin
4.61%
↓ 9.37%
Q3 FY22Q/Q Change
Revenue
1.9B
↓ 2.83%
Net Income
167.0M
↓ 10.89%
Net Profit Margin
9.0%
↓ 0.81%
Q4 FY22Q/Q Change
Revenue
7.5B
↑ 304.65%
Net Income
94.0M
↓ 43.71%
Net Profit Margin
1.25%
↓ 7.75%
Q1 FY23Q/Q Change
Revenue
1.8B
↓ 76.3%
Net Income
121.5M
↑ 29.26%
Net Profit Margin
6.82%
↑ 5.57%
Q2 FY23Q/Q Change
Revenue
1.7B
↓ 2.04%
Net Income
-7.3M
↓ 106.01%
Net Profit Margin
-0.42%
↓ 7.24%
Q3 FY23Q/Q Change
Revenue
1.7B
↓ 1.36%
Net Income
108.4M
↓ 1584.93%
Net Profit Margin
6.3%
↑ 6.72%
Q4 FY23Q/Q Change
Revenue
1.7B
↑ 0.15%
Net Income
98.5M
↓ 9.13%
Net Profit Margin
5.72%
↓ 0.58%
FY18Y/Y Change
Total Assets
9.9B
↓ 5.12%
Total Liabilities
13.0B
↓ 0.79%
FY19Y/Y Change
Total Assets
9.8B
↓ 1.4%
Total Liabilities
7.3B
↓ 43.6%
FY20Y/Y Change
Total Assets
9.9B
↑ 1.36%
Total Liabilities
7.2B
↓ 1.08%
FY21Y/Y Change
Total Assets
13.9B
↑ 40.28%
Total Liabilities
9.7B
↑ 34.13%
FY22Y/Y Change
Total Assets
13.5B
↓ 3.12%
Total Liabilities
8.6B
↓ 11.25%
FY23Y/Y Change
Total Assets
13.0B
↓ 3.65%
Total Liabilities
7.7B
↓ 10.32%
Q3 FY22Q/Q Change
Total Assets
13.1B
↓ 2.36%
Total Liabilities
8.5B
↓ 4.9%
Q4 FY22Q/Q Change
Total Assets
13.5B
↑ 2.68%
Total Liabilities
8.6B
↑ 1.02%
Q1 FY23Q/Q Change
Total Assets
13.4B
↓ 0.51%
Total Liabilities
8.4B
↓ 2.41%
Q2 FY23Q/Q Change
Total Assets
13.1B
↓ 2.48%
Total Liabilities
8.1B
↓ 4.16%
Q3 FY23Q/Q Change
Total Assets
12.8B
↓ 2.03%
Total Liabilities
7.7B
↓ 4.39%
Q4 FY23Q/Q Change
Total Assets
13.0B
↑ 1.36%
Total Liabilities
7.7B
↑ 0.28%
FY18Y/Y Change
Operating Cash Flow
200.5M
↓ 219.7%
Investing Cash Flow
-23.2M
↓ 99.65%
Financing Cash Flow
-170.3M
↓ 102.45%
FY19Y/Y Change
Operating Cash Flow
354.0M
↑ 76.56%
Investing Cash Flow
-42.1M
↑ 81.47%
Financing Cash Flow
-307.8M
↑ 80.74%
FY20Y/Y Change
Operating Cash Flow
929.8M
↑ 162.66%
Investing Cash Flow
-59.1M
↑ 40.38%
Financing Cash Flow
-782.9M
↑ 154.35%
FY21Y/Y Change
Operating Cash Flow
953.6M
↑ 2.56%
Investing Cash Flow
-4.1B
↑ 6874.11%
Financing Cash Flow
3.2B
↓ 511.19%
FY22Y/Y Change
Operating Cash Flow
843.6M
↓ 11.54%
Investing Cash Flow
-109.6M
↓ 97.34%
Financing Cash Flow
-648.7M
↓ 120.15%
Q3 FY22Q/Q Change
Operating Cash Flow
258.3M
↑ 13.54%
Investing Cash Flow
4.1M
↓ 109.98%
Financing Cash Flow
-219.4M
↓ 0.5%
Q4 FY22Q/Q Change
Operating Cash Flow
205.6M
↓ 20.4%
Investing Cash Flow
-33.1M
↓ 907.32%
Financing Cash Flow
-81.6M
↓ 62.81%
Q1 FY23Q/Q Change
Operating Cash Flow
219.5M
↑ 6.76%
Investing Cash Flow
-27.3M
↓ 17.52%
Financing Cash Flow
-275.0M
↑ 237.01%
Q2 FY23Q/Q Change
Operating Cash Flow
168.2M
↓ 23.37%
Investing Cash Flow
-29.4M
↑ 7.69%
Financing Cash Flow
-196.2M
↓ 28.65%
Q3 FY23Q/Q Change
Operating Cash Flow
230.7M
↑ 37.16%
Investing Cash Flow
-37.0M
↑ 25.85%
Financing Cash Flow
-188.4M
↓ 3.98%

Technicals Summary

Sell

Neutral

Buy

Avantor Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Avantor Inc
Avantor Inc
-0.91%
28.84%
34.35%
-24.68%
73.45%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
-1.16%
-15.34%
-17.71%
-18.99%
16.05%
Lyondellbasell Industries N.v.
Lyondellbasell Industries N.v.
-1.44%
10.93%
10.02%
-5.01%
13.26%
Linde Plc
Linde Plc
-5.07%
19.85%
21.6%
53.3%
148.98%
Sherwin-williams Company, The
Sherwin-williams Company, The
-10.87%
28.23%
33.16%
13.09%
100.24%
Ecolab Inc.
Ecolab Inc.
-3.7%
38.74%
35.19%
-3.1%
18.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Avantor Inc
Avantor Inc
54.17
54.17
NA
1.01
0.06
0.04
NA
7.76
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
22.41
22.41
1.37
12.32
0.15
0.05
0.03
66.91
Lyondellbasell Industries N.v.
Lyondellbasell Industries N.v.
15.55
15.55
1.8
8.26
0.16
0.06
0.05
39.85
Linde Plc
Linde Plc
35.35
35.35
2.65
14.48
0.15
0.06
0.01
82.33
Sherwin-williams Company, The
Sherwin-williams Company, The
32.35
32.35
4.16
11.43
0.72
0.1
0.01
13.88
Ecolab Inc.
Ecolab Inc.
46.09
46.09
2.33
6.39
0.18
0.06
0.01
23.46
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Avantor Inc
Avantor Inc
Buy
$17.3B
73.45%
54.17
4.61%
Air Products & Chemicals Inc.
Air Products & Chemicals Inc.
Buy
$52.2B
16.05%
22.41
18.82%
Lyondellbasell Industries N.v.
Lyondellbasell Industries N.v.
Hold
$32.8B
13.26%
15.55
5.14%
Linde Plc
Linde Plc
Buy
$214.0B
148.98%
35.35
18.87%
Sherwin-williams Company, The
Sherwin-williams Company, The
Buy
$77.2B
100.24%
32.35
10.52%
Ecolab Inc.
Ecolab Inc.
Hold
$63.1B
18.88%
46.09
8.96%

Institutional Holdings

  • Vanguard Group Inc

    9.62%

  • Dodge & Cox

    9.01%

  • T. Rowe Price Investment Management,Inc.

    7.75%

  • BlackRock Inc

    6.75%

  • Boston Partners Global Investors, Inc

    4.11%

  • Barrow Hanley Mewhinney & Strauss LLC

    3.59%

Company Information

based in center valley, pa (usa), avantor performance materials manufactures and markets high-performance chemistries and materials around the world under several respected brand names, including the j.t.baker®, macron fine chemicals™, rankem™, benesphera™, and poch™ brands. avantor products are used in a wide range of industries. our life sciences solutions are used in pharmaceutical production, laboratory research for academic, industry and quality control, and in medical lab testing. our electronics solutions are used in the manufacturing of semiconductors. for additional information please visit www.avantormaterials.com

Organization
Avantor Inc
Employees
14500
CEO
Mr. Michael Stubblefield
Industry
Chemicals: Specialty

Discover More

FAQs